HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial).

AbstractBACKGROUND:
Non-infarct-related artery (non-IRA) disease is prevalent in patients with ST-segment elevation myocardial infarction (STEMI). We aimed to assess the impact of non-IRA disease on infarct size and clinical outcomes in patients with acute STEMI.
METHODS:
The Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction (CRISP-AMI) trial randomized patients to intra-aortic balloon counterpulsation (IABC) vs no IABC prior to percutaneous coronary intervention in patients with acute STEMI. Infarct size (% left ventricular mass) at 3-5 days post percutaneous coronary intervention and 6-month clinical outcomes were compared between patients with and without non-IRA disease (defined as ≥50% stenosis in at least one non-IRA).
RESULTS:
A total of 324 (96.1%) patients had anterior STEMI, of whom 34.9% had non-IRA disease. There was no difference in infarct size (% left ventricular mass) between patients with and without non-IRA disease (median 39% vs 39%; P = .73). At 6 months, there was no difference in rates of recurrent myocardial infarction (0.9% vs 0.9%; P = .78), major Thrombolysis In Myocardial Infarction bleeding (0.9% vs 0.5%; P = .77), or all-cause death (3.5% vs 2.4%; P = .61) in patients with and without non-IRA disease, respectively. Patients with non-IRA disease had a higher rate of new/worsening heart failure with hospitalization (8.8% vs 1.9%; P = .0050).
CONCLUSIONS:
More than one-third of patients with anterior STEMI in the CRISP-AMI study had non-IRA disease. These patients had similar infarct sizes and rates of recurrent myocardial infarction, major bleeding, and all-cause death. Patients with non-IRA disease did have a higher rate of new/worsening heart failure with hospitalization. Further study is needed to understand the mechanisms of outcomes of patients with non-IRA disease.
AuthorsRohan Shah, Robert M Clare, Karen Chiswell, W Schuyler Jones, A Sreenivas Kumar, Holger Thiele, Richard W Smalling, Praveen Chandra, Marc Cohen, Divaka Perera, Derek P Chew, John K French, Jonathan Blaxill, E Magnus Ohman, Manesh R Patel
JournalThe American journal of medicine (Am J Med) Vol. 129 Issue 12 Pg. 1307-1315 (Dec 2016) ISSN: 1555-7162 [Electronic] United States
PMID27542611 (Publication Type: Journal Article)
CopyrightCopyright © 2016 Elsevier Inc. All rights reserved.
Topics
  • Comorbidity
  • Coronary Artery Disease (epidemiology, pathology)
  • Coronary Stenosis (epidemiology, pathology)
  • Female
  • Heart Failure (epidemiology)
  • Humans
  • Intra-Aortic Balloon Pumping (methods, statistics & numerical data)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Percutaneous Coronary Intervention (methods, statistics & numerical data)
  • Prevalence
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • ST Elevation Myocardial Infarction (diagnostic imaging, epidemiology, pathology, therapy)
  • Treatment Outcome
  • Ventricular Remodeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: